Characterisation and antimicrobial activity of essential oils of medicinal plants

泥盆纪健康集团是一家著名的植物制药公司，拥有针对全球未得到满足的医疗需求的新型治疗方法。泥盆纪健康集团的使命和愿景是将从药用植物提取物和植物精油中提取的循证抗菌产品商业化，用于有机和商业农产品市场。泥盆纪健康集团公司正专注于开发低成本、高效、具有抗微生物活性的植物产品，以防止北美使用植物过敏，重点放在农业部门，包括不断增长的大麻产品市场。通过第一次NSERC Engage，泥盆纪健康集团希望获得证据，对一系列植物提取物和精油的潜在抗真菌/抗微生物特性进行独立评估，并随后根据NSERC-Engage提案的PI S.Jabaji教授McGill进行的研究创建更有效的配方。总的主要目标是在将任何第一代产品商业化之前，了解几种植物提取物的抗真菌/抗微生物活性的微生物谱。此外，该项目产生的研究数据将使我们能够专注于特定的农业市场。这一合作为泥盆纪健康集团公司提供了一个独特的机会，以获得高通量(HTP)筛选方法，以选择在包括Cananbis在内的作物上以最低抑制浓度(MIC)应用的最有效的植物杀虫剂，并将其纳入公司的战略规划。最有效的植物性杀虫剂的确定为泥盆纪健康公司提供了关于植物性药物有效剂量的独立评估和科学证据，以及开发针对特定农业市场的单一疗法类型配方系列的生物技术潜力。

Devonian health Group Inc. is a renowned botanical pharmaceutical corporation with novel therapeutic approaches targeting worldwide unmet medical needs. The mission and vision of Devonian Health Group Inc. is to commercialize evidence-based antimicrobial products derived from medicinal plant extracts and essential oils of botanicals for organic and commercial agricultural markets. Devonian Health Group Inc. is focusing on developing low cost effective botanical products with antimicrobial activity to prevent phytopahtogens for use in North America focusing on the agricultural sector including the growing market of Cannabis products. With this first NSERC Engage, Devonian Health Group Inc. would like to obtain evidence that provides an independent assessment of the potential antifungal/antimicrobial properties of a wide range of botanical extracts and essential oils and subsequently create more potent formulations based on the research that will be performed by Professor S. Jabaji, McGill, the PI of this NSERC-ENGAGE proposal. The overall arching goal is to understand the microbiological spectrum of antifungal/antimicrobial activity of several botanical extracts before commercializing any first generation product. In addition, the research data generated by this project will allow us to focus on specific agricultural markets.This collaboration offers a unique opportunity to Devonian Health Group Inc. to acquire a high throughput (HTP) screening approach for selection of the most effective botanical pesticide applied at the minimum inhibitory concentration (MIC) to crops including Cananbis and incorporate it into the company's strategic planning. The identification of the most potent botanical pesticide provides Devonian Health Inc. an independent assessment and scientific evidence on the effective dose of the botanicals as well as the biotechnological potential to develop a monotherapy-type line of formulations targeted for specific agricultural markets.